Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Medical Equipment Industry Analysis

UpdatedSep 27, 2025
DataAggregated Company Financials
Companies235
  • 7D-1.2%
  • 3M-4.3%
  • 1Y-2.3%
  • YTD-1.2%

Over the last 7 days, the Medical Equipment industry has dropped 1.2%, driven by a pullback from Abbott Laboratories of 1.8%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the U.S. Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 27 Sep 2025US$1.3tUS$292.5bUS$31.4b27.9x41.1x4.4x
Mon, 25 Aug 2025US$1.4tUS$292.4bUS$31.4b30.3x43.3x4.7x
Wed, 23 Jul 2025US$1.3tUS$287.5bUS$30.1b31.1x43.7x4.6x
Fri, 20 Jun 2025US$1.3tUS$286.7bUS$29.6b30.1x44.2x4.6x
Sun, 18 May 2025US$1.4tUS$286.2bUS$29.3b33.4x46.9x4.8x
Tue, 15 Apr 2025US$1.2tUS$282.8bUS$27.7b29.1x45x4.4x
Thu, 13 Mar 2025US$1.3tUS$283.2bUS$27.4b31.9x48.2x4.7x
Sat, 08 Feb 2025US$1.4tUS$287.6bUS$30.5b35x46.4x4.9x
Mon, 06 Jan 2025US$1.3tUS$284.0bUS$23.6b34.5x55.4x4.6x
Wed, 04 Dec 2024US$1.3tUS$283.9bUS$23.4b37.1x57.5x4.7x
Fri, 01 Nov 2024US$1.3tUS$282.4bUS$23.2b35.8x56x4.6x
Sun, 29 Sep 2024US$1.3tUS$382.2bUS$32.8b39.8x40x3.4x
Tue, 27 Aug 2024US$1.3tUS$279.6bUS$22.2b35.5x58.4x4.6x
Thu, 25 Jul 2024US$1.3tUS$277.1bUS$22.8b38.9x55.6x4.6x
Sat, 22 Jun 2024US$1.3tUS$276.4bUS$22.7b36.7x55.2x4.5x
Mon, 20 May 2024US$1.3tUS$277.1bUS$23.0b37.9x55.6x4.6x
Wed, 17 Apr 2024US$1.2tUS$274.1bUS$23.9b37x52.1x4.5x
Fri, 15 Mar 2024US$1.3tUS$265.9bUS$22.6b37.9x56.8x4.8x
Sun, 11 Feb 2024US$1.3tUS$264.7bUS$22.4b35.4x56.1x4.7x
Tue, 09 Jan 2024US$1.2tUS$267.4bUS$20.1b37.7x59.6x4.5x
Thu, 07 Dec 2023US$1.1tUS$267.4bUS$20.1b35.4x56.5x4.3x
Sat, 04 Nov 2023US$1.1tUS$266.2bUS$19.3b35.1x55.8x4x
Mon, 02 Oct 2023US$1.1tUS$263.9bUS$15.0b34.5x74.3x4.2x
Wed, 30 Aug 2023US$1.2tUS$263.7bUS$15.0b35.1x79.9x4.5x
Fri, 28 Jul 2023US$1.3tUS$260.4bUS$15.0b36.9x86x5x
Sun, 25 Jun 2023US$1.3tUS$261.2bUS$16.2b36.7x78.5x4.9x
Tue, 23 May 2023US$1.3tUS$260.9bUS$16.7b36.4x75.5x4.8x
Thu, 20 Apr 2023US$1.3tUS$260.3bUS$18.5b37.8x68.4x4.9x
Sat, 18 Mar 2023US$1.1tUS$260.2bUS$18.6b37.1x61.1x4.4x
Mon, 13 Feb 2023US$1.2tUS$261.3bUS$19.4b35.2x60.9x4.5x
Wed, 11 Jan 2023US$1.2tUS$262.4bUS$20.8b33.8x56.5x4.5x
Fri, 09 Dec 2022US$1.1tUS$244.3bUS$19.0b32.6x59.1x4.6x
Sun, 06 Nov 2022US$1.0tUS$245.3bUS$22.1b32.1x47.1x4.3x
Tue, 04 Oct 2022US$1.0tUS$244.4bUS$26.5b32.7x38.9x4.2x
Price to Earnings Ratio

38.9x


Total Market Cap: US$1.0tTotal Earnings: US$26.5bTotal Revenue: US$244.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Medical Equipment Industry Price to Earnings3Y Average 57.4x202320242025
Current Industry PE
  • Investors are pessimistic on the American Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 41.1x which is lower than its 3-year average PE of 57.4x.
  • The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 5.8% per year over the last three years.
  • Revenues for these companies have grown 6.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-0.61%
Healthcare-0.80%
Medical Equipment-1.25%
Medical Equipment-1.15%
Medical Supplies-3.15%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 54.0x.
    • Analysts are expecting annual earnings growth of 11.7%, which is lower than the prior year's growth of 16.0% per year.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 32% over the next 5 years.
  • This is better than its past earnings growth rate of 0.7% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EW Edwards LifesciencesUS$76.252.5%
+US$1.1b		14.5%PE31.7x
ISRG Intuitive SurgicalUS$441.120.5%
+US$860.3m		-7.9%PE60.6x
BSX Boston ScientificUS$98.180.4%
+US$518.6m		17.8%PE58.1x
CLPT ClearPoint NeuroUS$21.5592.4%
+US$294.2m		92.6%PS18.2x
HOLX HologicUS$67.211.3%
+US$195.7m		-16.8%PE26.8x

Latest News

CLPT
US$21.55
ClearPoint Neuro
7D
92.4%
1Y
92.6%
GEHC
US$72.46
GE HealthCare Technologies
7D
-3.3%
1Y
-21.2%
ABT
US$133.55
Abbott Laboratories
7D
-1.8%
1Y
18.8%
MASI
US$141.40
Masimo
7D
0.7%
1Y
6.2%
SYK
US$369.02
Stryker
7D
-2.1%
1Y
2.4%
HOLX
US$67.21
Hologic
7D
1.3%
1Y
-16.8%
EW
US$76.25
Edwards Lifesciences
7D
2.5%
1Y
14.5%

Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching

Sep 20
Why Edwards Lifesciences Corporation (NYSE:EW) Could Be Worth Watching
MDT
US$94.22
Medtronic
7D
-0.9%
1Y
5.5%
PODD
US$318.00
Insulet
7D
-3.9%
1Y
37.1%

Digital Diabetes Care Will Expand International Market Opportunities

Analysts have modestly raised Insulet’s price target, citing strong Q2 earnings, accelerated international Omnipod 5 adoption, and favorable reimbursement trends outweighing regulatory risks, resulting in a consensus target increase from $355.17 to $360.17. Analyst Commentary Bullish analysts cited Insulet's beat on Q2 earnings estimates, which prompted broad guidance raises and higher outlooks for FY25, reflecting renewed momentum in core business metrics.
PMI
US$8.70
Picard Medical
7D
15.5%
1Y
n/a
BDX
US$184.60
Becton Dickinson
7D
-1.3%
1Y
-23.6%
BAX
US$21.98
Baxter International
7D
-4.5%
1Y
-43.5%
ISRG
US$441.12
Intuitive Surgical
7D
0.5%
1Y
-7.9%
USBC
US$1.16
USBC
7D
27.5%
1Y
-90.9%
BSX
US$98.18
Boston Scientific
7D
0.4%
1Y
17.8%
IDXX
US$632.22
IDEXX Laboratories
7D
-3.6%
1Y
23.5%

Advanced Diagnostics And International Expansion Will Define Future Opportunity

IDEXX Laboratories’ consensus price target has been sharply raised, reflecting strengthened revenue growth forecasts and a higher future P/E multiple, with fair value increasing from $542.55 to $657.55. What's in the News IDEXX Laboratories raised 2025 earnings guidance, increasing revenue outlook to $4,205–$4,280 million (up $90 million at midpoint) and EPS to $12.40–$12.76 (up $0.40 at midpoint), reflecting strong recurring diagnostics revenue, higher inVue Dx instrument placements, and favorable foreign exchange.